Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease

International Journal of Cardiology

Volumn 114, Issue 3, 2007, Pages 339-344

  Koch, Andreas ^a   Kitzsteiner, Tobias ^a   Zink, Stefan ^a   Cesnjevar, Robert ^a   Singer, Helmut ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

BNP; Cardiac surgery; Congenital heart disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; LACTIC ACID;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CELL PROTECTION; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEMODYNAMICS; HUMAN; INFANT; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 33845231079     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.01.022     Document Type: Article

References (37)

1. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
2. Cowie M.R., and Mendez G.F. BNP and congestive heart failure. Prog Cardiovasc Dis 44 (2002) 293-321
3. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
4. Crilley J.G., and Farrer M. Left ventricular remodelling and brain natriuretic peptide after the first myocardial infarction. Heart 86 (2001) 638-642
5. Bolger A.P., Sharma R., Li W., et al. Neurohumoral activation and the congenital heart failure syndrome in adults with congenital heart disease. Circulation 106 (2002) 92-99
6. Book W.M., Hott B.J., and McConnel M. B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am J Cardiol 95 (2005) 545-546
7. Tulevski I.I., Groenink M., van der Wall E.E., et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 86 (2001) 27-30
8. Law Y.M., Keller B.B., Feingold B.M., and Boyle G.J. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 95 (2005) 474-478
9. Westerlind A., Wahlander H., Lindstedt G., Lundberg P.A., and Holmgren D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93 (2004) 340-345
10. Nir A., Bar-Oz B., Perles Z., Korach A., and Rein A.J.J.T. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 93 (2004) 603-607
11. Mir T.S., Marohn S., Laer S., Eiselt M., Grollmus O., and Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110 (2002) e76
12. Cowley C.G., Bradley J.D., and Shaddy R.E. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25 (2004) 336-340
13. Suda K., Matsumura M., and Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45 (2003) 249-254
14. Koch A., Zink S., and Singer H. B-type natriuretic peptide in patients with congenital heart disease. Cardiol Young 15 Suppl. 2 (2005) 15
15. Koch A., and Singer H. Plasma levels of B-type natriuretic peptide in children and adolescents with aortic valve stenosis. Eur Heart J 26 (2005) 1688-1689 10.1093/eurheartj/ehi369
16. Koch A., and Singer H. Normal values of B-type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
17. Rauh M., and Koch A. Plasma N-terminal pro B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 49 (2003) 1563-1564
18. Del Ry S., Giannessi D., and Clerico A. Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared. Clin Chem Lab Med 39 (2001) 446-450
19. Wieczorek S.J., Wu A.H.B., Christenson R., et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 142 (2002) 834-839
20. Mair P., Mair J., Bleier J., Hörmann C., Balogh D., and Puschendorf B. Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest. Clin Chim Acta 261 (1997) 57-68
21. Morimoto K., Mori T., Ishiguro S., Matsuda N., Hara Y., and Kuroda H. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today 28 (1998) 23-29
22. Avidan M.S., Meehan N., Ponte J., El-Gamel A., and Sherwood R.A. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta 303 (2001) 127-132
23. Watanabe M., Egi K., Hasegawa S., et al. Significance of serum atrial and brain natriuretic peptide release after coronary artery bypass grafting. Surg Today 33 (2003) 671-673
24. Berendes E., Schmidt C., Van Aken H., et al. A-type and B-type natriuretic peptides in cardiac surgical procedures A. Anesth Analg 98 (2004) 11-19
25. Hutfless R., Kazanegra R., Madani M., et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43 (2004) 1873-1879
26. Bail D.H.L., Kofler M., and Ziemer G. Brain natriuretic peptide (BNP) in patients undergoing coronary artery bypass grasfting. Thorac Cardiovasc Surg 52 (2004) 135-140
27. Ationu A., Singer D.R., Smith A., et al. Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc Res 27 (1993) 1538-1541
28. Clerico A., Prontera C., Emdin M., et al. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP. Clin Chem 51 (2005) 445-457
29. Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
30. D'Souza S.P., Yellon D.M., Martin C., et al. B-type natriuretic peptide (BNP) limits infarct size in rat isolated heart via K-ATP channel opening. Am J Physiol Heart Circ Physiol 284 (2003) H1592-H1600
31. Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
32. Talwar S., Squire I.B., Downie P.F., Davies J.E., and Ng L.L. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84 (2000) 421-424
33. D'Souza S.P., and Baxter G.F. B-type natriuretic peptide: a good omen in myocardial ischemia. Heart 89 (2003) 707-709
34. Rosenkranz A.C., Woods R.L., Dusting G.J., and Ritchie R.H. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res 57 (2003) 515-522
35. Knowles J.W., Esposito G., Mao L., et al. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107 (2001) 975-984
36. Cao L., and Gardner D. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25 (1995) 227-234
37. Tamura N., Ogawa Y., Chusho H., et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 97 (2000) 4239-4244